Please use this identifier to cite or link to this item: https://hdl.handle.net/10419/278513 
Year of Publication: 
2023
Series/Report no.: 
Research Paper No. 178
Publisher: 
South Centre, Geneva
Abstract: 
The unequal global distribution of vaccines against the deadly COVID-19 virus has cast a spotlight on the lack of access to vaccines on the African continent, and the vulnerability that such a lack places on both the economies of African nations and the health of their people. Various initiatives have been launched to overcome the dependence of African nations on vaccines produced elsewhere. If implemented in timely and effective ways, those initiatives will contribute to the diversification of African economies and strengthen the capacity of nations on the continent to address their public health needs during pandemics and at other times. While establishing a viable vaccine industry on the continent presents serious challenges, the African Continental Free Trade Area (AfCFTA) can provide the framework for leveraging economies of scale to stimulate the production of needed vaccines across the region.
Subjects: 
Access to Medicines
Access to Vaccines
Africa
African Continental Free Trade Area (AfCFTA)
African Union (AU)
COVID-19
Global Health
Health
Intellectual Property
Pandemic
Public Health
Vaccine Equity
Vaccine Industry
Vaccine Inequity
Vaccine Nationalism
Vaccine Production
Vaccines
Document Type: 
Research Report
Appears in Collections:

Files in This Item:
File
Size





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.